NEUROSURGICAL SURVEY. By Valentino Cassinari and Carlo A. Pagni. (Pp. xi+ 192. 63s). Harvard University Press (Dist. in Great Britain by Oxford University Press, London), 1969. THIS book is a synopsis of world literature and personal experience of the authors in the problems of physiopathogenesis and treatment of central pain. The opening chapter reviews knowledge and theories concerning the pa...

The management of movement disorders has been historically treated with both surgical and medical modalities. While L-Dopa has been the medical mainstay for Parkinson’s Disease, surgical techniques have evolved over the past century to the current state of stereotactic procedures in focal parts of the central nervous system. Presented here is a review of the history of this evolution. Over the ...

Neurosurgery is not a first-choice treatment for chronic pain. It is indicated when chronic pain is insufficiently relieved by analgesics, or when medication is effective but causes unacceptable side effects. Neurosurgical procedures may be ablative or augmentative (stimulating). An ablative procedure interrupts pain pathways at one of various levels in the central nervous system (CNS). In cont...

Neoplastic brachial plexopathy (NBP) is caused by a cancerous infiltration into the brachial plexus, presenting often as severe pain in the affected upper extremity. Such pain can be resistant to medical treatment. Invasive interventions such as brachial plexus neurolysis with phenol or cordotomy may result in severe complications including permanent neurological damage and death. Continuous br...

STUDY DESIGN A retrospective study. PURPOSE The purpose of this study was to obtain useful information for establishing the guidelines for treating high-grade spinal cord gliomas. OVERVIEW OF LITERATURE The optimal management of high-grade spinal cord gliomas remains controversial. We report the outcomes of the surgical management of 14 high-grade spinal glioma. METHODS We analyzed the ou...

Monoclonal antibody Cat-301 recognizes a surface antigen on subsets of neurons in many areas of the mammalian CNS, including Y-cells in the cat dorsal lateral geniculate nucleus (LGN) and spinal motor neurons in several species. We have shown previously that the Cat-301 antigen is expressed relatively late in postnatal development, with a time course that matches that of late developmental feat...